Navigation Links
Connecticut Governor Dannel P. Malloy, U.S. Senator Richard Blumenthal Open StemCONN 2013
Date:4/4/2013

NEW HAVEN, Conn., April 4, 2013 /PRNewswire-iReach/ -- Connecticut Governor Dannel P. Malloy and United States Senator for Connecticut Richard Blumenthal opened the proceedings today at StemCONN 2013, a day-long symposium that brought together internationally renowned stem cell researchers from Connecticut and beyond.

"Over the course of the past two years, Connecticut has made tremendous investments in bioscience and technology — supporting the expansion of these industries and building partnerships between the private sector and our public universities, hospitals, and economic development entities," said Governor Malloy. "We welcome this phenomenal group of researchers, doctors, and innovators to StemConn 2013, and we encourage you to explore Connecticut's leadership in the field."

"Today's StemCONN symposium was an inspiring demonstration of the powerful role Connecticut scientists play in leading international stem cell research," Senator Blumenthal said. "I will continue to advocate for robust federal investment in stem cell and other life-saving breakthrough research. This research is not only vital to our health and wellbeing as individuals, but also to the health of our national and local economies."

In addition to presentations on the latest in stem cell research, the day's events included a panel discussion on "Realizing the Potential" that included Edison Liu , M.D., of The Jackson Laboratory, which is building a new facility for genomic medicine in Farmington, and Jonathan Rothberg , Ph.D., the Connecticut entrepreneur behind many of today's state-of-the-art gene sequencing technologies.

The program also featured stem cell leaders Lawrence Goldstein , Ph.D., of the University of California, San Diego and David Scadden , M.D., of the Harvard Stem Cell Institute. At a pre-conference breakfast, Mark Tomishima , Ph.D., of the Sloan-Kettering Institute spoke on stem cell therapy for Parkinson's disease.

Connecticut research was presented at the symposium by Laura Grabel , Ph.D., of Wesleyan University, Jonathan Covault , M.D., Ph.D., of UConn Health Center and Jun Lu , Ph.D., of Yale University.

The StemCONN symposium at the Omni Hotel in New Haven included a display of 99 scientific posters that featured recent and as yet unpublished research predominantly from stem cell research laboratories in Connecticut. Research in the posters covered a wide area, from the use of stem cells as therapeutic agents to the mechanisms regulating stem cell activity and their utility as models of disease, among other subjects.

One hundred high school and undergraduate students from throughout Connecticut attended StemCONN at no cost thanks to a Connecticut Stem Cell Initiative grant to the Human Embryonic Stem Cell Core Facility at UConn Health Center and Wesleyan University.

"Connecticut has become a major player in the area of stem cell research," said Dr. Diane Krause , Chair of the StemCONN 2013 organizing committee and associate director of the Yale Stem Cell Center. "We're proud to demonstrate how the state's investment in stem cell research is paying off."

With its pioneering stem cell legislation in 2005, Connecticut became just the third state in the nation to provide public funding in support of human embryonic and adult stem cell research. The legislation established advisory and peer review committees, with the Commissioner of Public Health as chair. Commissioner Jewel Mullen was among the speakers welcoming the audience at StemCONN 2013.

The StemCONN symposium has been held every two years since 2007. In addition to Dr. Krause, symposium organizers included Caroline Dealy , Ph.D. of the Center for Regenerative Medicine and Skeletal Development, UConn Stem Cell Institute, University of Connecticut Health Center; David Goldhamer , Ph.D., of the Center For Regenerative Biology, UConn Stem Cell Institute, University of Connecticut; Marianne Horn , R.N., J.D., of the Office of Research and Development, State of Connecticut Department of Public Health; Janice Naegele , Ph.D., of the Program in Neuroscience and Behavior, Wesleyan University; Paul Pescatello , J.D., Ph.D. of CURE (Connecticut United for Research Excellence, Inc.); Lawrence Rizzolo , Ph.D. of the Department of Surgery and Ophthalmology, Yale University; and Milton Wallack , D.D.S., of the Connecticut Stem Cell Coalition.

The scientific meeting was organized under the auspices of CURE. Core sponsors are: Connecticut Department of Public Health; Economic Development Corporation of New Haven; Life Technologies LLC; University of Connecticut Stem Cell Center; Yale Stem Cell Center; and Wesleyan University.

Media Contact:

Bill Kelly CURE (Connecticut United for Research Excellence), 203-375-2696,

bill@harveymalis.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE CURE (Connecticut United for Research Excellence)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
2. Medbox, Inc. Rides a Wave of Local Media Support in Connecticut
3. Connecticut Radiology Group Leverages MedInformatix RIS to Achieve Stage 1 Meaningful Use Objectives
4. Dr. Susan Froshauer to join Connecticut bioscience team at CURE
5. First Telescopic Implant in Connecticut for Macular Degeneration
6. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
7. Governor Gregoire and Congressman McDermott Join Novo Nordisk at Opening Event for Type 1 Diabetes Research Center in Seattle
8. Governor Corbett: Lancaster County Commercial Lab to Expand, Create 200 New Jobs
9. Governor Corbett: Pharmaceutical and Medical Device Packaging Company to Create New Jobs in Lehigh Valley
10. Health Diagnostic Laboratory, Inc. hosts Town Hall Meeting with Governor Tim Kaine and Senator Mark Warner
11. Senator Blumenthal, a Strong Advocate for Womens Health, Visits Hologics Manufacturing Facility in Danbury, CT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... , July 26, 2017 E.I. Medical Imaging ... the Bimini SharkLab to custom design the worlds first ultrasound system ... sharks in their native habitat. In preparation for a ... Channel,s Shark Week, Dr. Guttridge approached EIMI with the ... diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology:
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... services business of UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership ... affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBI) over the ...
(Date:8/20/2017)... ... ... Are you an adult with gluten intolerance or Celiac disease living with ... participating in a research study that focuses on family interactions when dealing with dietary ... aspects of adults who have gluten sensitivities who cohabitate with other adults who may ...
(Date:8/19/2017)... , ... August 19, 2017 , ... ... that it is the first organization with pending recognition status from the Centers ... Program (“DPP”) via group telehealth classes and live video conferencing. , The ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... joined its Orlando location as an interventional pain management physician. He brings a ... the treatment of migraine headaches, and significant experience in spinal cord stimulation for ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport ... a definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner ...
Breaking Medicine News(10 mins):